UroGen Pharma
URGN
URGN
43 hedge funds and large institutions have $454M invested in UroGen Pharma in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+2
Holders Change %
+4.88%
% of All Funds
0.99%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
10
Increased
21
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
PA
Perceptive Advisors
New York
|
-$7.41M |
2 |
SIM
Spark Investment Management
New York
|
-$2.63M |
3 |
LCM
Laurion Capital Management
New York
|
-$1.77M |
4 |
LSC
Lyon Street Capital
Sausalito,
California
|
-$1.18M |
5 |
HCM
Highline Capital Management
New York
|
-$1.15M |